EUVIMEDEUVIMED entdecken
LeserbriefLeitlinieOpen Access

Antibiotic use in Barcelona in 2023 in primary care and the potential reduction by adjusting box sizes to current guidelines

L Alonso Acero, I Quiles-Melero, M J Jaras-Hernández, C Toro

Revista Española de Quimioterapia · 2024

DOI: 10.37201/req/054.2023 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Revista Española de Quimioterapia, 2024. Verfasst von L Alonso Acero und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laura Alonso Acero, Microbiology Department, Hospital Universitario La Paz, Paseo de la Castellana 261, 28046, Madrid, Spain. laura.a.acero@gmail.com. Hauptthemen laut MEDLINE: Mycobacterium, Tuberculosis, Mycobacterium tuberculosis, Mycobacterium Infections, Nontuberculous. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Prior research has not examined the size of antibiotic packages prescribed. We assessed 2023 prescription rates in Barcelona and the most prescribed presentations in pharmacies, while evaluating potential reductions if all amoxicillin and amoxicillin/clavulanate containers had 20 doses.

Methods

Antibiotics prescribed by primary care doctors working for the Catalonian Health Institute in Barcelona in 2023 were analysed by calculating the defined daily doses per 1,000 inhabitants and day (DID).

Results

The observed prescribing rate was 8 DID, with penicillins accounting for 4.6 DID (57.2%). The most frequently prescribed antibiotics were amoxicillin and amoxicillin/clavulanate, making up 4.4 DID. If all the 30-dose presentations of amoxicillin and amoxicillin/clavulanate had been 20-dose containers, the total number of DIDs would have been 3.3, resulting in a reduction of 1.1 DID (25.4% less).

Conclusions

Antibiotic prescribing rate in Barcelona was low. Aligning the dosage of antibiotics with established guidelines could further reduce antibiotic consumption.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MycobacteriumTuberculosisMycobacterium tuberculosisMycobacterium Infections, NontuberculousHumansNontuberculous Mycobacteria

Stichwörter der Autor:innen

Lung Diseasemycobacterium shimoideinon-tuberculous mycobacteriumtuberculosis-like disease

Autor:innen und Institutionen

  • Laura Alonso Acero, Microbiology Department, Hospital Universitario La Paz, Paseo de la Castellana 261, 28046, Madrid, Spain. laura.a.acero@gmail.com.

Zitieren

APA

Alonso Acero, L., Quiles-Melero, I., Jaras-Hernández, M. J., & Toro, C. (2024). Antibiotic use in Barcelona in 2023 in primary care and the potential reduction by adjusting box sizes to current guidelines. Revista Española de Quimioterapia. https://doi.org/10.37201/req/054.2023

Vancouver

Alonso Acero L, Quiles-Melero I, Jaras-Hernández MJ, Toro C. Antibiotic use in Barcelona in 2023 in primary care and the potential reduction by adjusting box sizes to current guidelines. Revista Española de Quimioterapia. 2024. doi:10.37201/req/054.2023

BibTeX
@article{AlonsoAcero2024,
  author = {Alonso Acero, L and Quiles-Melero, I and Jaras-Hernández, M J and Toro, C},
  title = {Antibiotic use in Barcelona in 2023 in primary care and the potential reduction by adjusting box sizes to current guidelines},
  journal = {Revista Española de Quimioterapia},
  year = {2024},
  doi = {10.37201/req/054.2023}
}
Kostenlos starten →